Hemoglobinopathies Market Overview
The Hemoglobinopathies Market size report has estimated the industry size to be USD 6.31 billion in 2022. The Hemoglobinopathies Market is expected to expand from USD 6.48 billion in 2023 to USD 9.95 billion by 2032, at a compound annual growth rate (CAGR) of 7.20% during the forecast period (2023-2032).
The Hemoglobinopathies Market is gaining traction as a result of continuous research and rising global awareness of these inherited blood illnesses. While advances in genetic medicines and enhanced screening efforts are driving market expansion, obstacles such as limited access to specialised treatments and healthcare disparities are limiting market growth. The increasing prevalence of hemoglobinopathies worldwide, as well as the demand for novel therapeutics such as gene-editing techniques, serve as powerful motivators. Disparities in healthcare access and affordability, on the other hand, can limit patients' access to cutting-edge treatments.
As the market seeks towards inclusion and affordability, it is positioned to revolutionise hemoglobinopathies management. The Hemoglobinopathies Market maintains a dedication to research, accessibility, and worldwide collaboration while navigating the delicate balance between progress and equitable healthcare solutions.
The global hemoglobinopathies market is segmented based on type, treatment, test types, and region.
The global market for hemoglobinopathies, by type, is segmented into thalassemia, sickle cell disease, and other Hb variants diseases. The thalassemia segment is further classified as alpha thalassemia and beta thalassemia. The sickle cell disease segment is expected to hold the largest market share of the hemoglobinopathies market owing to the presence of strong product pipelines such as LentiGlobin and rising prevalence of sickle cell disease.
Based on treatment, the market is classified into stem-cell transplantation, blood transfusions, analgesics, antibiotics, ACE inhibitors, and hydroxyurea. Also, based on treatment, the blood transfusion segment holds the largest market share owing to significant success rate and increasing adoption of this treatment option.
The market by end user, has been segmented into hospitals & clinics, diagnostics laboratories, and others.
On the basis of region, the global hemoglobinopathies market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Some of the key players listed in the hemoglobinopathies market overview report are Sanofi, Sangamo Therapeutics Inc., Global Blood Therapeutics, Bluebird Bio Inc., Emmaus Life Sciences Inc., Prolong Pharmaceuticals, Celgene Corporation, Alnylam Pharmaceuticals, Gamida Cell, Acceleron Pharma, Mast Therapeutic, HemaQuest Pharmaceuticals, and Invenux.
The global hemoglobinopathies market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The hemoglobinopathies market in the Americas has further been segmented into North America and South America, with the North America market further classified into the US and Canada.
The European hemoglobinopathies market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The hemoglobinopathies market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The hemoglobinopathies market in the Middle East & Africa has been segmented into the Middle East and Africa.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]